ResMed RMD Business Segments
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| Net revenue by Business | ||||||
| Residential Care Software | $170.89M+6.0% | $166.87M+6.6% | $166.14M+6.0% | $167.01M+9.9% | $161.16M+8.9% | |
| Sleep and Breathing Health | $1.26B+11.5% | $1.26B+11.6% | $1.17B+9.5% | $1.18B+10.2% | $1.13B+7.8% | |
| Operating Income (Loss) by Business | ||||||
| Residential Care Software | $58.24M+9.5% | $50.05M+2.4% | $54.02M+13.4% | $55.32M+29.8% | $53.18M+37.2% | |
| Sleep And Breathing Health | $575.41M+16.3% | $571.85M+17.0% | $530.62M+15.1% | $519.89M+17.8% | $494.8M+8.5% | |
| Selling, general, and administrative by Business | ||||||
| Residential Care Software | $35.56M+2.4% | $39.55M+17.2% | $36.33M-0.8% | $38.43M+6.8% | $34.72M-3.6% | |
| Sleep And Breathing Health | $149.51M+23.0% | $147.74M+24.3% | $134.73M+23.1% | $141.78M+25.7% | $121.56M+7.7% | |
| Cost of Sales by Business | ||||||
| Residential Care Software | $50.86M+5.2% | $51.48M+3.4% | $50.82M+5.2% | $48.52M+2.0% | $48.35M+1.7% | |
| Sleep And Breathing Health | $479.19M+2.6% | $482.25M+3.1% | $453.19M+0.8% | $468.17M+5.1% | $466.98M+4.8% | |
| Business acquisitions by Business | ||||||
| Residential Care Software | $0— | —— | —— | $0— | $0— | |
| Sleep And Breathing Health | $18.94M-25.2% | —— | —— | $25.33M— | $25.33M— | |
| Depreciation and amortization by segment by Business | ||||||
| Residential Care Software | $2.75M+22.3% | $2.73M+22.0% | $2.62M+10.5% | $2.61M+8.8% | $2.25M-4.5% | |
| Sleep And Breathing Health | $36.86M+61.5% | $27.31M+8.2% | $25.03M+8.8% | $39.46M+81.3% | $22.82M+4.5% | |
| R&D by Business | ||||||
| Residential Care Software | $26.23M+5.3% | $25.79M+7.1% | $24.96M+3.1% | $24.74M+3.6% | $24.92M+4.4% | |
| Sleep And Breathing Health | $56.41M+19.4% | $54.1M+8.0% | $50.9M+6.3% | $51.14M+9.7% | $47.24M+1.3% | |
| Goodwill (note 4) by Business | ||||||
| Residential Care Software | $2.14B+2.5% | $2.16B+5.0% | $2.16B+2.1% | $2.16B+3.8% | $2.09B— | |
| Sleep And Breathing Health | $898.83M+18.6% | $883.95M+18.3% | $883.79M+14.9% | $883.58M+16.6% | $757.81M— | |
| Goodwill, Foreign Currency Translation, Gain (Loss) by Business | ||||||
| Residential Care Software | -$16.11M-149% | —— | -$2.77M-109% | $71.99M— | $32.78M— | |
| Sleep And Breathing Health | -$4.06M-138% | —— | -$1.11M-109% | $24.35M— | $10.79M— | |
| Adjustment to fair values of preliminary purchase price allocations by Business | ||||||
| Residential Care Software | $0— | $0— | $0— | $0— | $0— | |
| Net revenue by segment by Product | ||||||
| Devices | $1.47B+8.8% | $1.45B+8.5% | $1.36B+8.7% | —— | $1.35B+6.0% | |
| Masks and other | $1.05B+15.5% | $1.06B+16.1% | $978.27M+10.7% | —— | $908.74M+10.6% | |
| Residential Care Software | $170.89M+6.0% | $166.87M+6.6% | $166.14M+6.0% | $167.01M+9.9% | $161.16M+8.9% | |
| Sleep And Breathing Health | $1.26B+11.5% | $1.26B+11.6% | $1.17B+9.5% | $1.18B+10.2% | $1.13B+7.8% | |
| Cost of sales (exclusive of amortization shown separately below) by Product | ||||||
| Residential Care Software | $50.86M+5.2% | $51.48M+3.4% | $50.82M+5.2% | $48.52M+4.4% | $48.35M+0.8% | |
| Sleep And Breathing Health | $481.72M+2.6% | $484.79M+2.4% | $456.12M+1.1% | $470.04M+3.7% | $469.54M+4.7% | |
| Amortization of Intangible Assets by Product | ||||||
| Residential Care Software | $6.43M+2.7% | $6.39M-0.2% | $6.4M-0.9% | $6.34M-6.2% | $6.26M-7.3% | |
| Sleep And Breathing Health | $1.42M+20.2% | $1.42M+15.0% | $1.42M+17.4% | $3.02M+148% | $1.18M+12.1% | |
| Net revenue by segment by Geography | ||||||
| Combined Europe, Asia and other markets | $441.84M+15.9% | $420.91M+11.8% | $394.69M+9.5% | $389.04M+13.1% | $381.26M+5.5% | |
| Global revenue | $1.43B+10.8% | $1.42B+11.0% | $1.34B+9.1% | —— | $1.29B+7.9% | |
| U.S., Canada and Latin America | $818.67M+9.3% | $835.03M+11.5% | $774.75M+9.5% | —— | $749.32M+9.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ResMed break its business down?
- ResMed (RMD) reports net revenue by business across 2 parts — Residential Care Software and Sleep and Breathing Health. Each is extracted from the segment footnotes and tracked over time.
- Where does ResMed's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ResMed's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
